CEACAM5 and neoplasm: BiTEs targeted against carcinoembryonic antigen (CD3xCEA) were also found to increase T-cell tumour killing with an increase in tumour cell PD-L1 expression, both in vivo with animal studies [20], and in vitro with co-cultured human tumour cells [12].